Skip to content

Chiesi Group Forges Alliance with Karolinska Institute to Tackle Urgent Health Issues

The collaboration is underpinned by a shared commitment to advancing medical science and improving patient care through joint research, development, and innovation efforts. One of the initial focuses under this agreement is to deepen collaboration in the area of early-onset respiratory diseases caused by preterm birth. The Chiesi Group, a research-driven [...]

Chiesi Group Forges Alliance with Karolinska Institute to Tackle Urgent Health Issues
author avatar
LabNews Media LLC
The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They are bestselling authors, science writers and science journalists since 1994.More details about their writing on X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
See Full Bio
LabNews Media LLC

LabNews Media LLC

The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They have been bestselling authors, science writers, and science journalists since 1994.More details about their writing at X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu

Similar Posts

Genetic tests drive demand for ALS centers of excellence in the US

TeaserThe expansion of genetic testing for amyotrophic lateral sclerosis (ALS) will lead to a significant increase in clinic visits to specialized ALS centers over the next ten years. A…

more »Genetic testing drives demand for ALS specialty centers in the US

Fraunhofer IAP develops microencapsulated adhesives for "adhesive on demand"

Potsdam (LabNews Media LLC) – Researchers at the Fraunhofer Institute for Applied Polymer Research IAP have developed a process for encapsulating adhesives in microcapsules, which only then…

more »Fraunhofer IAP develops microencapsulated adhesives for "adhesive on demand"

First CAR T-cell therapy against solid tumors approved in China

Shanghai (LabNews Media LLC) – China's regulatory authority NMPA has approved Satri-cel (CT041, Kaileimei®), the world's first CAR T-cell therapy for the treatment of a solid tumor.…

more »First CAR T-cell therapy against solid tumors approved in China